R Rottscholl
Overview
Explore the profile of R Rottscholl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
41
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boeer B, Oberlechner E, Rottscholl R, Gruber I, Guergan S, Brucker S, et al.
Sci Rep
. 2024 Aug;
14(1):18370.
PMID: 39112604
The aim of this study was to evaluate the long-term efficacy of a single ultrasound-guided high-intensity focused ultrasound (US-HIFU) treatment in patients with breast fibroadenoma (FA) in terms of volume...
2.
Reiter R, Brosch S, Rottscholl R, Smith E
Laryngorhinootologie
. 2013 Aug;
92(8):541-2.
PMID: 23900925
No abstract available.
3.
Smith E, Rottscholl R, Brosch S, Reiter R
Laryngorhinootologie
. 2013 Jun;
92(6):381-8.
PMID: 23740416
Malignant haematological diseases such as the highly malignant diffuse large B-cell lymphoma, the MALT-lymphoma and the extramedullary plasmocytoma are seldom located in the larynx. In this review, clinical symptoms, laryngoscopic...
4.
Pickhard A, Smith E, Rottscholl R, Brosch S, Reiter R
Laryngorhinootologie
. 2012 Oct;
91(12):758-66.
PMID: 23044789
Chronic inflammatory diseases including tuberculosis, rheumatic disorders (rheumatoid arthritis, sarcoidosis, systemic lupus erythematosus, Wegeners's granulomatosis, relapsing polychondritis) and reflux disease are considered as systemic diseases, and may affect the larynx....
5.
Schwentner L, Wolters R, Koretz K, Wischnewsky M, Kreienberg R, Rottscholl R, et al.
Breast Cancer Res Treat
. 2011 Dec;
132(3):1073-80.
PMID: 22205141
Triple-negative breast cancer (TNBC) (ER-/PGR-/erb-2-) constitutes an aggressive subtype in breast cancer because it is accompanied by a significant decrease in overall survival (OAS) and recurrence-free survival (RFS) compared with...